Fig. 2. Ex vivo and in vivo investigation of the mechanism of drug delivery enhancement with ultrasound. Ex vivo and in vivo investigation of the mechanism.

Slides:



Advertisements
Similar presentations
Fig. 1. TP is highly expressed in myeloma.
Advertisements

Fig. 3. Ultrasound-mediated BMP-6 gene delivery to mini-pig tibial bone fractures. Ultrasound-mediated BMP-6 gene delivery to mini-pig tibial bone fractures.
In vivo responses of AMLMLL to ATRi.
Fig. 4. Biomechanical properties of treated tibiae.
Fig. 3. 3RMR response to graded ischemia ex vivo.
Fig. 3. A circadian rhythm in fibroblast wound-healing response.
Fig. 5. Pharmacological JAK2 inhibition in vivo abrogates tumor-initiating potential after chemotherapy. Pharmacological JAK2 inhibition in vivo abrogates.
Fig. 5. In vivo characterization of adipogenesis by CT.
Nuclear calcium signaling drives nuclear actin polymerization in T cells. Nuclear calcium signaling drives nuclear actin polymerization in T cells. (A)
Fig. 7 Improvement of clinical score and axon pathology by nasal IL-4 treatment during chronic EAE. Improvement of clinical score and axon pathology by.
Fig. 4. Local application of FR provides prolonged protection against Gq-dependent airway constriction in normal and OVA-sensitized mice in vivo. Local.
Arp2/3-mediated formation of nuclear actin networks is essential for CD4+ T cell effector functions. Arp2/3-mediated formation of nuclear actin networks.
Fig. 4. Peanut-specific TH2A cells are specifically targeted during immunotherapy. Peanut-specific TH2A cells are specifically targeted during immunotherapy.
Fig. 5 Quantitative assessment of the efficacy of the tissue-engineered implant to heal the TMJ disc defect. Quantitative assessment of the efficacy of.
Fig. 1 ZIKV RNA in blood and tissues.
Consolidated Standards of Reporting Trials flow diagram of VRC trial
Fig. 2 Whisker deprivation accelerates and enhances behavioral recovery after right S1FP photothrombosis. Whisker deprivation accelerates and enhances.
Fig. 1. Loss of circadian rhythms in iKO mice.
LIMK1 inhibition protects against Aβ-induced neuronal hyperexcitability. LIMK1 inhibition protects against Aβ-induced neuronal hyperexcitability. (A) Representative.
Fig. 4 Labeling of Msmeg with DMN-Tre is fast and specific and depends on Ag85A function. Labeling of Msmeg with DMN-Tre is fast and specific and depends.
Fig. 2. Clinically actionable somatic genomic alterations in various tumor types. Clinically actionable somatic genomic alterations in various tumor types.
Fig. 5. Microarray analysis of tumors treated by dabrafenib, trametinib, or the combination of dabrafenib and trametinib with pmel-1 ACT or mock ACT. Microarray.
Fig. 1. Schematic showing the shedding of tumor DNA from head and neck cancers into the saliva or plasma. Schematic showing the shedding of tumor DNA from.
Fig. 1. MSCs undergo in vivo apoptosis after infusion without affecting immunosuppression. MSCs undergo in vivo apoptosis after infusion without affecting.
Fig. 1. Iontophoretic devices used for the delivery of cytotoxic agents to solid tumors. Iontophoretic devices used for the delivery of cytotoxic agents.
In vivo release of doxycycline hyclate from the GRS in a swine model
The applications of the biohybrid structural color hydrogels in a heart-on-a-chip system. The applications of the biohybrid structural color hydrogels.
Fig. 5. In vivo characterization of adipogenesis by CT.
Fig. 3 Implantation of the battery-free optofluidic nerve cuff system and its impact on animal behavior and nerve health. Implantation of the battery-free.
Full-frame single image recording the violation of a Bell inequality
Fig. 6. Ex vivo and in vivo test to evaluate the sealing capability of the MeTro sealant using a porcine lung incision model. Ex vivo and in vivo test.
Fig. 1. CAR4 and CAR8 cells demonstrate in vitro and in vivo antileukemic efficacy. CAR4 and CAR8 cells demonstrate in vitro and in vivo antileukemic efficacy.
Fig. 1. DEL-1 is expressed by human and mouse osteoclasts.
Fig. 7 BMS reduces the elevated expression of type I IFN–regulated genes both ex vivo in blood from patients with lupus and in a phase 1 study of.
Fig. 1. Detection of circulating tumor DNA in CRPC patients.
by Joan B. Mannick, Melody Morris, Hans-Ulrich P
Fig. 3 1D NMR. 1D NMR. Time-domain (left) and frequency-domain (right) NV NMR signals for (A) water, (B) trimethyl phosphate (TMP), and (C) 1,4-difluorobenzene.
The microchip-based drug delivery device and overview of study design
Motions of the biohybrid robot powered by the antagonistic pair of skeletal muscle tissues. Motions of the biohybrid robot powered by the antagonistic.
Fig. 7. CIVO performance in canine lymphoma tumors demonstrates spatially restricted responses linked to drug mechanism. CIVO performance in canine lymphoma.
Auditory-somatosensory bimodal stimulation desynchronizes brain circuitry to reduce tinnitus in guinea pigs and humans by Kendra L. Marks, David T. Martel,
Type I collagen–targeted PET probe for pulmonary fibrosis detection and staging in preclinical models by Pauline Désogère, Luis F. Tapias, Lida P. Hariri,
Fig. 6. C3 deficiency resulted in partial sparing of neuron loss in hippocampal CA3 in 16-month-old APP/PS1 mice. C3 deficiency resulted in partial sparing.
Galloping-like gait with the design of a two-legged robot.
Ultrasound-Mediated Gene Therapy in Swine Livers Using Single-Element, Multi-lensed, High-Intensity Ultrasound Transducers  Misty L. Noble-Vranish, Shuxian.
Fig. 2 PK dosing results. PK dosing results. (A) Plasma concentration of hPTH(1–34) versus time after release of 40-μg dose from implanted microchip device.
Fig. 3. In vivo tumor responses are mechanism of action–specific and concentration-dependent. In vivo tumor responses are mechanism of action–specific.
Fig. 1 Most models of biological responses to climate change omit important biological mechanisms. Most models of biological responses to climate change.
Fig. 3 Prophylactic or therapeutic use of DECON protects from herpes infections in vitro. Prophylactic or therapeutic use of DECON protects from herpes.
Fig. 3. Human liver tissue seed graft function.
Tissue architecture affects function of expanded liver seed grafts
Fig. 7. Gradient of adipocyte size and FAI around the human coronaries in the presence or absence of coronary atherosclerosis. Gradient of adipocyte size.
Long-range structural order control of SS-annealed cylinder patterns
Fig. 4 In vivo evaluation of insulin complex for type 1 diabetic mice treatment. In vivo evaluation of insulin complex for type 1 diabetic mice treatment.
Fig. 2 BX795 is nontoxic to HCE cells at therapeutic concentration.
Fig. 6. Combinatorial VCPI and OV M1 treatment is efficacious in vivo and ex vivo. Combinatorial VCPI and OV M1 treatment is efficacious in vivo and ex.
Fig. 2. Mechanism of PD-L1 down-regulation in NOD HSPCs.
Fig. 8 DMN-Tre detects Mtb in sputum samples from patients with tuberculosis, similar to the auramine stain. DMN-Tre detects Mtb in sputum samples from.
Fig. 7. Altered morphology after ultrasound but unaltered numbers of microglia in SUS-treated mice. Altered morphology after ultrasound but unaltered numbers.
Fig. 3. Association between peak CTL019 expansion and response.
Fig. 3 Time-domain interferogram and rf heterodyne beat notes.
Fig. 1. Schematic description of whole-exome or targeted next-generation sequencing analyses. Schematic description of whole-exome or targeted next-generation.
Fig. 7. Nanowarming maintains biomechanical properties of porcine carotid arteries. Nanowarming maintains biomechanical properties of porcine carotid arteries.
Fig. 3 Ect2 gene inactivation lowers cardiomyocyte endowment and is lethal in mice. Ect2 gene inactivation lowers cardiomyocyte endowment and is lethal.
Fig. 6 Pharmacologic alterations of β-AR signaling regulate cardiomyocyte abscission and endowment. Pharmacologic alterations of β-AR signaling regulate.
Fig. 3 Postnatal assembly of the humanized gut microbiota.
Fig. 2. In vitro sealing properties of the MeTro sealant.
In vivo function of MeTro sealants using rat incision model of lungs
Fig. 3. Effects of SFN in mice with diet-induced diabetes.
Fig. 2. In vivo local CD25-targeted NIR-PIT induces regression of treated LL/2-luc tumors. In vivo local CD25-targeted NIR-PIT induces regression of treated.
Presentation transcript:

Fig. 2. Ex vivo and in vivo investigation of the mechanism of drug delivery enhancement with ultrasound. Ex vivo and in vivo investigation of the mechanism of drug delivery enhancement with ultrasound. (A) Relative enhancement in glucose delivery to small intestine as a result of 40°C heating for 2 or 5 min or 20-kHz ultrasound at 7.5 W/cm2 at a duty cycle of 50% for 2 min total. (B) Relative enhancement in glucose delivery to small intestine as a result of treatment with 1-MHz ultrasound set to 2 W/cm2 (5.22 W actual) for 3.4 min, stirring of the donor chamber, or 40-kHz ultrasound set to an intensity of 13.4 W/cm2. (C) Number of pits generated in aluminum foil after treatment with 20-, 40-, 60-kHz, or 1-MHz ultrasound for 2 s at the highest intensity considered for each frequency. In (A) to (C), data are averages ± 1 SD; P values were determined by one-way analysis of variance (ANOVA) with multiple comparisons. (D) Representative images of pitted aluminum foil samples treated with either 20-, 40-, or 60-kHz ultrasound. Scale bar, 3 mm. (E and F) Averaged Gaussian filtered amplitude spectrum of six fast Fourier transforms (FFTs) taken on in situ acoustic data collected externally in vivo in pigs during f = 20 kHz UMGID along with a representative amplitude spectrum for each repeat (E) and a control when ultrasound was not on (F). (G) Estimation of pore size radii created in porcine small intestine tissue and permeability (averages ± 1 SD) of glucose and inulin as a result of ultrasound exposure using the aqueous porous pathway model. Carl M. Schoellhammer et al., Sci Transl Med 2015;7:310ra168 Copyright © 2015, American Association for the Advancement of Science